Genmab — Januar 2017
-
Selvfølgelig..Det skal man gøre med udsagn fra stort set alle.
-
bibob - det er Janssen der stemmer hvad Darzalex kombeneres (ikke Genmab). Så hvis Darzalex skal kombineres med tisotumab, så skal Genmab overbevise Janssen om at det er en god ide.
-
OK tak for klarifikationen Sukkeralf

-
Mayflower - det er ikke en 50/50 aftale som Janssen og Genmab har. Janssen skal betale op til 20% I royalties til Genmab for al Darzalex salg
-
Mayflower - jeg det er forkert at sige at Janssen / Genmab ejer Darzalex 50/50
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind